jRCT2031210444已完成不适用
SJP-0008 Phase I -Drug-Drug Interaction Study in Healthy Japanese Adult Subjects-
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 24
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized Controlled Trial
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 55age old under（—）
- 性别
- All
入选标准
- •Healthy Japanese male and female
- •20-55 years of age at the time of the informed consent
- •Other protocol-specified inclusion criteria may apply
排除标准
- •History or complications of diseases such as the heart, kidneys, liver, and brain that are considered inappropriate for participation in this clinical trial
- •History or complications of serious drug allergies or food allergies
- •Judged by the investigator, etc. to be ineligible for this clinical trial
- •Other protocol-specified exclusion criteria may apply
结局指标
主要结局
-
Plasma concentration of compound(s)
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian MenNon-alcoholic SteatohepatitisNCT04722653Novo Nordisk A/S42
已完成
1 期
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese MenHealthy Volunteers Type 2 DiabetesNCT04878406Novo Nordisk A/S24
已完成
1 期
A Study in Healthy Japanese and Caucasian Subjects to Assess the Pharmacokinetics, Safety and Tolerability of RisankizumabHealthy VolunteersNCT05305222AbbVie17
已完成
不适用
A single dose study in healthy Japanese participants to evaluate the safety and pharmacokinetics of otilimab.Rheumatoid ArthritisjRCT2071210132GlaxoSmithKline K.K.12
未知
Unknown
Administration study of stimulants to healthy Japanese adult femalesot applicableJPRN-jRCT1080222264Mitsubishi chemical Medience Corporation18